34512303|t|Amelioration of Hippocampal Insulin Resistance Reduces Tau Hyperphosphorylation and Cognitive Decline Induced by Isoflurane in Mice.
34512303|a|General anesthetics can induce cognitive impairments and increase the risk of Alzheimer's disease (AD). However, the underlying mechanisms are still unknown. Our previous studies shown that long-term isoflurane exposure induced peripheral and central insulin resistance (IR) in adult mice and aggravated IR in type 2 diabetes mellitus (T2DM) mice. Clinical and preclinical studies revealed an association between impaired insulin signaling and tau pathology in AD and other tauopathies. We investigated if alleviation of hippocampal IR by the antidiabetic agent metformin could reduce tau hyperphosphorylation and cognitive decline induced by isoflurane in mice. The effects of prolonged (6 h) isoflurane anesthesia on hippocampal IR, hippocampal tau hyperphosphorylation, and hippocampus-dependent cognitive function were evaluated in wild type (WT) adult mice and the high-fat diet plus streptozotocin (HFD/STZ) mouse model of T2DM. Here we shown that isoflurane and HFD/STZ dramatically and synergistically induced hippocampal IR and fear memory impairment. Metformin pretreatment strongly ameliorated hippocampal IR and cognitive dysfunction caused by isoflurane in WT mice, but was less effective in T2DM mice. Isoflurane also induced hippocampal tau hyperphosphorylation and metformin reversed this effect. In addition, isoflurane significantly increased blood glucose levels in both adult and T2DM mice, and metformin reversed this effect as well. Administration of 25% glucose to metformin-pretreated mice induced hyperglycemia, but surprisingly did not reverse the benefits of metformin on hippocampal insulin signaling and fear memory following isoflurane anesthesia. Our findings show hippocampal IR and tau hyperphosphorylation contribute to acute isoflurane-induced cognitive dysfunction. Brief metformin treatment can mitigate these effects through a mechanism independent of glycemic control. Future studies are needed to investigate whether long-term metformin treatment can also prevent T2DM-induced hippocampal IR and cognitive decline.
34512303	84	101	Cognitive Decline	Disease	MESH:D003072
34512303	113	123	Isoflurane	Chemical	MESH:D007530
34512303	127	131	Mice	Species	10090
34512303	164	185	cognitive impairments	Disease	MESH:D003072
34512303	211	230	Alzheimer's disease	Disease	MESH:D000544
34512303	232	234	AD	Disease	MESH:D000544
34512303	333	343	isoflurane	Chemical	MESH:D007530
34512303	384	402	insulin resistance	Disease	MESH:D007333
34512303	404	406	IR	Disease	MESH:D007333
34512303	417	421	mice	Species	10090
34512303	437	439	IR	Disease	MESH:D007333
34512303	443	467	type 2 diabetes mellitus	Disease	MESH:D003924
34512303	469	473	T2DM	Disease	MESH:D003924
34512303	475	479	mice	Species	10090
34512303	594	596	AD	Disease	MESH:D000544
34512303	607	618	tauopathies	Disease	MESH:D024801
34512303	666	668	IR	Disease	MESH:D007333
34512303	695	704	metformin	Chemical	MESH:D008687
34512303	718	742	tau hyperphosphorylation	Disease	MESH:C536599
34512303	747	764	cognitive decline	Disease	MESH:D003072
34512303	776	786	isoflurane	Chemical	MESH:D007530
34512303	790	794	mice	Species	10090
34512303	827	837	isoflurane	Chemical	MESH:D007530
34512303	864	866	IR	Disease	MESH:D007333
34512303	990	994	mice	Species	10090
34512303	1022	1036	streptozotocin	Chemical	MESH:D013311
34512303	1042	1045	STZ	Chemical	MESH:D013311
34512303	1047	1052	mouse	Species	10090
34512303	1062	1066	T2DM	Disease	MESH:D003924
34512303	1087	1097	isoflurane	Chemical	MESH:D007530
34512303	1106	1109	STZ	Chemical	MESH:D013311
34512303	1163	1165	IR	Disease	MESH:D007333
34512303	1170	1192	fear memory impairment	Disease	MESH:D008569
34512303	1194	1203	Metformin	Chemical	MESH:D008687
34512303	1250	1252	IR	Disease	MESH:D007333
34512303	1257	1278	cognitive dysfunction	Disease	MESH:D003072
34512303	1289	1299	isoflurane	Chemical	MESH:D007530
34512303	1306	1310	mice	Species	10090
34512303	1338	1342	T2DM	Disease	MESH:D003924
34512303	1343	1347	mice	Species	10090
34512303	1349	1359	Isoflurane	Chemical	MESH:D007530
34512303	1414	1423	metformin	Chemical	MESH:D008687
34512303	1459	1469	isoflurane	Chemical	MESH:D007530
34512303	1494	1507	blood glucose	Chemical	MESH:D001786
34512303	1533	1537	T2DM	Disease	MESH:D003924
34512303	1538	1542	mice	Species	10090
34512303	1548	1557	metformin	Chemical	MESH:D008687
34512303	1610	1617	glucose	Chemical	MESH:D005947
34512303	1621	1630	metformin	Chemical	MESH:D008687
34512303	1642	1646	mice	Species	10090
34512303	1655	1668	hyperglycemia	Disease	MESH:D006943
34512303	1719	1728	metformin	Chemical	MESH:D008687
34512303	1788	1798	isoflurane	Chemical	MESH:D007530
34512303	1841	1843	IR	Disease	MESH:D007333
34512303	1893	1903	isoflurane	Chemical	MESH:D007530
34512303	1912	1933	cognitive dysfunction	Disease	MESH:D003072
34512303	1941	1950	metformin	Chemical	MESH:D008687
34512303	2100	2109	metformin	Chemical	MESH:D008687
34512303	2137	2141	T2DM	Disease	MESH:D003924
34512303	2162	2164	IR	Disease	MESH:D007333
34512303	2169	2186	cognitive decline	Disease	MESH:D003072
34512303	Negative_Correlation	MESH:D008687	MESH:D003924
34512303	Negative_Correlation	MESH:D007530	MESH:D008687
34512303	Positive_Correlation	MESH:D013311	MESH:D008569
34512303	Association	MESH:D007530	MESH:D003924
34512303	Negative_Correlation	MESH:D008687	MESH:D007333
34512303	Positive_Correlation	MESH:D001786	MESH:D007530
34512303	Positive_Correlation	MESH:D013311	MESH:D007333
34512303	Negative_Correlation	MESH:D001786	MESH:D008687
34512303	Positive_Correlation	MESH:D013311	MESH:D003924
34512303	Positive_Correlation	MESH:D007530	MESH:D008569
34512303	Positive_Correlation	MESH:D008687	MESH:D006943
34512303	Positive_Correlation	MESH:D005947	MESH:D006943
34512303	Negative_Correlation	MESH:D008687	MESH:C536599
34512303	Negative_Correlation	MESH:D008687	MESH:D003072
34512303	Positive_Correlation	MESH:D007530	MESH:D007333
34512303	Positive_Correlation	MESH:D007530	MESH:D003072

